Oral Turinabol is suppressive to natural testosterone and should be used in conjunction with exogenous testosterone. Men who use Oral Turinabol without exogenous testosterone will risk a low testosterone condition. Such a condition can come with a host of possible symptoms ranging from physical, mental and sexually related. However, while physical related symptoms are unlikely when steroids are being used the others are a very real possibility.
Once the use of Oral Turinabol comes to an end natural testosterone production will begin again on its own. However, natural levels will still be very low and it will take a large amount of time to recover proper or healthy levels. For this reason most men are encouraged to implement a Post Cycle Therapy (PCT) plan once the use of anabolic steroids is discontinued. This will greatly speed up the recovery process and protect your lean tissue. Without a PCT plan it is possible for cortisol to become dominant for a period of time, destroy muscle tissue and promote fat gain. While a PCT plan will promote recovery, it will not return you to normal on its own. There is no PCT plan on earth that has this ability. However, a well planned PCT will speed up the process and ensure you have enough testosterone for proper bodily function while your levels continue to naturally rise.
There are a few important notes on natural recovery, the primary being that no low testosterone condition existed prior to anabolic steroid use. Further, natural recovery assumes no severe damage was done to the Hypothalamic-Pituitary-Testicular-Axis (HPTA) through improper anabolic steroid use. As a final note, women have no need to supplement with exogenous testosterone when using Oral Turinabol.
All anabolic steroids possess the capability to suppress and/or shut down the body’s natural endogenous Testosterone production, and Turinabol side effects are no exception to this fact. Despite the fact that Turinabol exhibits perhaps the lowest androgenic rating out of all anabolic steroids, it would still nevertheless suppressive over the course of a full cycle length. It is therefore highly advised that any Turinabol user engage in a proper PCT (Post Cycle Therapy) protocol, which should always include the use of Testosterone production stimulating ancillary compounds, such as Nolvadex and/or HCG (Human Chorionic Gonadotropin) for an average PCT period of 4 – 6 weeks following the end of a cycle of any anabolic steroid regardless of how ‘mild’ it is claimed to be in terms of its impacts on the HPTA. No anabolic steroid cycle, whether it includes a compound that is considered as safe as Turinabol, should ever end without a PCT protocol superseding it. Failure to do so can result in permanent damage to the HPTA, whereby the individual will insufficiently produce proper levels of Testosterone for the remainder of his life, which if left untreated will ultimately medical intervention in the form of TRT (Testosterone Replacement Therapy).
As a cutting agent, Oral Turinabol can be a good option. The steroid will provide solid protection against lean tissue loss and a lot of users often report an increase in muscle hardness. It will not provide the level of hardness of Stanazolol, Masteron or Trenbolone. However, the lean tissue protection and increases in endurance and recovery can prove invaluable for athletes whom have high injury risk. This is a great steroid to use at the frontend of a long cutting cycle and then once a little leaner to switch over to more aggressive anabolics.